Novo Holdings-backed Windward Bio raises $175 million in US IPO

Nov 12 (Reuters) – Novo Holdings-backed Windward Bio said on Thursday it had raised $175 million in its US initial public offering afterselling about 10.3 million shares at $17 apiece. The IPO price

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)